Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease
- PMID: 36426677
- DOI: 10.1002/ppul.26227
Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease
Abstract
The field of rare and diffuse pediatric lung disease is experiencing rapid progress as diagnostic and therapeutic options continue to expand. In this annual review, we discuss manuscripts published in Pediatric Pulmonology in 2021 in (1) children's interstitial and diffuse lung disease, (2) congenital airway and lung malformations, and (3) noncystic fibrosis bronchiectasis including primary ciliary dyskinesia. These include case reports, descriptive cohorts, trials of therapies, animal model studies, and review articles. The results are put into the context of other literature in the field. Each furthers the field in important ways, while also highlighting the continued need for further studies.
Keywords: bronchiectasis; congenital abnormalities; interstitial lung disease; primary ciliary dyskinesia.
© 2022 Wiley Periodicals LLC.
Similar articles
-
Pediatric Pulmonology 2022 year in review: Rare and diffuse lung disease.Pediatr Pulmonol. 2023 Oct;58(10):2719-2724. doi: 10.1002/ppul.26603. Epub 2023 Jul 26. Pediatr Pulmonol. 2023. PMID: 37493100 Review.
-
Pediatric Pulmonology 2023 year in review: Rare and diffuse lung disease.Pediatr Pulmonol. 2024 Oct;59(10):2428-2434. doi: 10.1002/ppul.27108. Epub 2024 May 31. Pediatr Pulmonol. 2024. PMID: 38818884 Review.
-
Pediatric pulmonology 2020 year in review: Rare and diffuse lung disease.Pediatr Pulmonol. 2022 Apr;57(4):807-813. doi: 10.1002/ppul.25807. Epub 2022 Jan 17. Pediatr Pulmonol. 2022. PMID: 34964566 Review.
-
Pediatric pulmonology 2019 year in review: rare and diffuse lung disease.Pediatr Pulmonol. 2021 Jun;56(6):1324-1331. doi: 10.1002/ppul.25297. Epub 2021 Feb 9. Pediatr Pulmonol. 2021. PMID: 33559960 Review.
-
Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease.Pediatr Pulmonol. 2025 Apr;60(4):e71096. doi: 10.1002/ppul.71096. Pediatr Pulmonol. 2025. PMID: 40243387 Free PMC article. Review.
References
REFERENCES
-
- Kurland G, Deterding RR, Hagood JS, et al. An official American thoracic society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188(3):376-394. doi:10.1164/rccm.201305-0923ST
-
- Fan LL, Dishop MK, Galambos C, et al. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc. 2015;12(10):1498-1505. doi:10.1513/AnnalsATS.201501-064OC
-
- Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120-1128. doi:10.1164/rccm.200703-393OC
-
- Deterding R, Griese M, Deutsch G, et al. Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease. ERJ Open Res. 2021;7(2):00805-2020. doi:10.1183/23120541.00805-2020
-
- Kerby GS, Wagner BD, Popler J, et al. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol. 2013;48(10):1008-1015. doi:10.1002/ppul.22718
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical